The DAPA‐DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity—A longitudinal cohort study

Abstract Objective The cardio‐renal benefits of sodium glucose‐like transporter 2 inhibitor (SGLT2i) therapies have been demonstrated in patients with and without type 2 diabetes. However, no studies have explored the long‐term metabolic effects of SGLT2i, combined with dietary carbohydrate restrict...

Description complète

Détails bibliographiques

Auteurs principaux:	Petra Hanson, Harpal Randeva, Dan J. Cuthbertson, Paul J. O'Hare, Nick Parsons, Kamaljit Chatha, Gemma Reidy, Martin O. Weickert, Thomas M. Barber
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2022-11-01
Collection:	Endocrinology, Diabetes & Metabolism
Sujets:	appetite carbohydrate restriction energy expenditure fat mass lean mass metabolism
Accès en ligne:	https://doi.org/10.1002/edm2.381
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!